vs
InvenTrust Properties Corp.（IVT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
InvenTrust Properties Corp.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$77.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 8.6%），InvenTrust Properties Corp.自由现金流更多（$110.9M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.6%）
InvenTrust Properties Corp.是一家专注于购物中心投资的房地产投资信托基金，截至2024年12月31日，公司共持有68处物业的权益，总建筑面积达1100万平方英尺，在商业地产投资领域拥有成熟的运营布局与资产储备。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
IVT vs PBYI — 直观对比
营收规模更大
IVT
是对方的1.0倍
$75.5M
营收增速更快
PBYI
高出19.1%
8.6%
自由现金流更多
IVT
多$96.5M
$14.4M
两年增速更快
PBYI
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.4M | $75.5M |
| 净利润 | $2.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -11.0% | 22.7% |
| 净利率 | 3.4% | — |
| 营收同比 | 8.6% | 27.7% |
| 净利润同比 | -72.8% | — |
| 每股收益（稀释后） | $0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVTPBYI
| Q4 25 | $77.4M | $75.5M | ||
| Q3 25 | $74.5M | $54.5M | ||
| Q2 25 | $73.6M | $52.4M | ||
| Q1 25 | $73.8M | $46.0M | ||
| Q4 24 | $71.2M | $59.1M | ||
| Q3 24 | $68.5M | $80.5M | ||
| Q2 24 | $67.4M | $47.1M | ||
| Q1 24 | $66.8M | $43.8M |
净利润IVTPBYI
| Q4 25 | $2.7M | — | ||
| Q3 25 | $6.0M | $8.8M | ||
| Q2 25 | $95.9M | $5.9M | ||
| Q1 25 | $6.8M | $3.0M | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-539.0K | $20.3M | ||
| Q2 24 | $1.5M | $-4.5M | ||
| Q1 24 | $2.9M | $-4.8M |
毛利率IVTPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率IVTPBYI
| Q4 25 | -11.0% | 22.7% | ||
| Q3 25 | -9.8% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | -10.5% | 8.7% | ||
| Q4 24 | -3.6% | 22.6% | ||
| Q3 24 | -18.7% | 27.4% | ||
| Q2 24 | -13.6% | -4.6% | ||
| Q1 24 | -13.1% | -5.3% |
净利率IVTPBYI
| Q4 25 | 3.4% | — | ||
| Q3 25 | 8.1% | 16.2% | ||
| Q2 25 | 130.4% | 11.2% | ||
| Q1 25 | 9.2% | 6.5% | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | -0.8% | 25.2% | ||
| Q2 24 | 2.2% | -9.6% | ||
| Q1 24 | 4.3% | -11.0% |
每股收益（稀释后）IVTPBYI
| Q4 25 | $0.02 | $0.26 | ||
| Q3 25 | $0.08 | $0.17 | ||
| Q2 25 | $1.23 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $-0.01 | $0.41 | ||
| Q2 24 | $0.02 | $-0.09 | ||
| Q1 24 | $0.04 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $825.9M | $22.7M |
| 股东权益账面价值 | $1.8B | $130.3M |
| 总资产 | $2.8B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.46× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资IVTPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务IVTPBYI
| Q4 25 | $825.9M | $22.7M | ||
| Q3 25 | $764.6M | $34.0M | ||
| Q2 25 | $746.3M | $45.3M | ||
| Q1 25 | $740.7M | $56.7M | ||
| Q4 24 | $740.4M | $68.0M | ||
| Q3 24 | $740.1M | $79.3M | ||
| Q2 24 | $812.2M | $90.7M | ||
| Q1 24 | $827.5M | $102.0M |
股东权益IVTPBYI
| Q4 25 | $1.8B | $130.3M | ||
| Q3 25 | $1.8B | $115.3M | ||
| Q2 25 | $1.8B | $104.7M | ||
| Q1 25 | $1.7B | $97.1M | ||
| Q4 24 | $1.8B | $92.1M | ||
| Q3 24 | $1.8B | $71.1M | ||
| Q2 24 | $1.5B | $48.5M | ||
| Q1 24 | $1.5B | $51.0M |
总资产IVTPBYI
| Q4 25 | $2.8B | $216.3M | ||
| Q3 25 | $2.7B | $202.9M | ||
| Q2 25 | $2.7B | $194.9M | ||
| Q1 25 | $2.6B | $196.2M | ||
| Q4 24 | $2.6B | $213.3M | ||
| Q3 24 | $2.6B | $220.7M | ||
| Q2 24 | $2.5B | $205.0M | ||
| Q1 24 | $2.5B | $214.1M |
负债/权益比IVTPBYI
| Q4 25 | 0.46× | 0.17× | ||
| Q3 25 | 0.42× | 0.30× | ||
| Q2 25 | 0.41× | 0.43× | ||
| Q1 25 | 0.42× | 0.58× | ||
| Q4 24 | 0.42× | 0.74× | ||
| Q3 24 | 0.42× | 1.12× | ||
| Q2 24 | 0.53× | 1.87× | ||
| Q1 24 | 0.53× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $155.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $110.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 143.3% | 19.1% |
| 资本支出强度资本支出/营收 | 57.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 58.41× | — |
| 过去12个月自由现金流最近4个季度 | $193.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流IVTPBYI
| Q4 25 | $155.4M | $14.4M | ||
| Q3 25 | $43.8M | $9.7M | ||
| Q2 25 | $48.7M | $14.1M | ||
| Q1 25 | $20.2M | $3.6M | ||
| Q4 24 | $136.9M | $15.6M | ||
| Q3 24 | $38.4M | $11.0M | ||
| Q2 24 | $46.7M | $1.0M | ||
| Q1 24 | $14.8M | $11.2M |
自由现金流IVTPBYI
| Q4 25 | $110.9M | $14.4M | ||
| Q3 25 | $31.4M | $9.7M | ||
| Q2 25 | $38.0M | $14.1M | ||
| Q1 25 | $12.8M | $3.6M | ||
| Q4 24 | $100.8M | $15.6M | ||
| Q3 24 | $29.3M | $11.0M | ||
| Q2 24 | $37.2M | $1.0M | ||
| Q1 24 | $7.7M | — |
自由现金流率IVTPBYI
| Q4 25 | 143.3% | 19.1% | ||
| Q3 25 | 42.2% | 17.7% | ||
| Q2 25 | 51.6% | 26.8% | ||
| Q1 25 | 17.4% | 7.7% | ||
| Q4 24 | 141.5% | 26.4% | ||
| Q3 24 | 42.8% | 13.7% | ||
| Q2 24 | 55.2% | 2.1% | ||
| Q1 24 | 11.5% | — |
资本支出强度IVTPBYI
| Q4 25 | 57.5% | 0.0% | ||
| Q3 25 | 16.7% | 0.0% | ||
| Q2 25 | 14.6% | 0.0% | ||
| Q1 25 | 10.0% | 0.1% | ||
| Q4 24 | 50.7% | 0.0% | ||
| Q3 24 | 13.3% | 0.0% | ||
| Q2 24 | 14.0% | 0.0% | ||
| Q1 24 | 10.6% | 0.0% |
现金转化率IVTPBYI
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | 1.10× | ||
| Q2 25 | 0.51× | 2.41× | ||
| Q1 25 | 2.97× | 1.21× | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
